Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Oyster Point Pharma, Inc. (OYST) since 2019 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Oyster Point Pharma, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1720725.
Total stock buying since 2019: $59,028,668.
Total stock sales since 2019: $24,523,950.
Total stock option exercises since 2019: $555,144.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2021 | 0 | $0 | 1,650,000 | $24,523,950 | 112,699 | $457,964 |
| 2020 | 182,571 | $5,103,868 | 0 | $0 | 13,000 | $97,180 |
| 2019 | 3,370,300 | $53,924,800 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2021-11 | 0 | $0 | 0 | $0 | 8,590 | $98,870 |
| 2021-10 | 0 | $0 | 1,650,000 | $24,523,950 | 50,000 | $51,000 |
| 2021-09 | 0 | $0 | 0 | $0 | 17,500 | $96,525 |
| 2021-07 | 0 | $0 | 0 | $0 | 7,500 | $86,325 |
| 2021-04 | 0 | $0 | 0 | $0 | 10,000 | $10,200 |
| 2021-02 | 0 | $0 | 0 | $0 | 19,109 | $115,044 |
| 2020-09 | 0 | $0 | 0 | $0 | 4,000 | $46,040 |
| 2020-08 | 4,000 | $103,880 | 0 | $0 | 4,000 | $46,040 |
| 2020-07 | 0 | $0 | 0 | $0 | 5,000 | $5,100 |
| 2020-05 | 178,571 | $4,999,988 | 0 | $0 | 0 | $0 |
| 2019-11 | 3,370,300 | $53,924,800 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-11-01 | Lochner Daniel (Chief Financial Officer) | Option Ex | 8,590 | 11.51 | 98,870 |
| 2021-10-21 | Nau Jeffrey (President and CEO) | Option Ex | 50,000 | 1.02 | 51,000 |
| 2021-10-18 | Ozawa Clare (Director) | Sale | 550,000 | 14.86 | 8,174,650 |
| 2021-10-18 | Versant Side Fund Iv, L.p. (10% Owner) | Sale | 550,000 | 14.86 | 8,174,650 |
| 2021-10-18 | Link William J Phd (Director) | Sale | 550,000 | 14.86 | 8,174,650 |
| 2021-09-02 | Lochner Daniel (Chief Financial Officer) | Option Ex | 7,500 | 11.51 | 86,325 |
| 2021-09-01 | Nau Jeffrey (President and CEO) | Option Ex | 10,000 | 1.02 | 10,200 |
| 2021-07-28 | Lochner Daniel (Chief Financial Officer) | Option Ex | 7,500 | 11.51 | 86,325 |
| 2021-04-02 | Nau Jeffrey (President and CEO) | Option Ex | 10,000 | 1.02 | 10,200 |
| 2021-02-24 | Lochner Daniel (Chief Financial Officer) | Option Ex | 9,109 | 11.51 | 104,844 |
| 2021-02-19 | Nau Jeffrey (President and CEO) | Option Ex | 10,000 | 1.02 | 10,200 |
| 2020-09-25 | Lochner Daniel (Chief Financial Officer) | Option Ex | 4,000 | 11.51 | 46,040 |
| 2020-08-11 | Lochner Daniel (Chief Financial Officer) | Option Ex | 4,000 | 11.51 | 46,040 |
| 2020-08-10 | Snisarenko John (Chief Commercial Officer) | Buy | 4,000 | 25.97 | 103,880 |
| 2020-07-28 | Nau Jeffrey (President and CEO) | Option Ex | 5,000 | 1.02 | 5,100 |
| 2020-05-19 | Lainovic Sacha (Director) | Buy | 178,571 | 28.00 | 4,999,988 |
| 2019-11-04 | Kkr Associates Hcsg L.p. | Buy | 155,000 | 16.00 | 2,480,000 |
| 2019-11-04 | Lochner Daniel (Chief Financial Officer) | Buy | 6,300 | 16.00 | 100,800 |
| 2019-11-04 | Nau Jeffrey (President and CEO) | Buy | 1,000 | 16.00 | 16,000 |
| 2019-11-04 | Snisarenko John (Chief Commercial Officer) | Buy | 3,000 | 16.00 | 48,000 |
| 2019-11-04 | Ozawa Clare (Director) | Buy | 562,500 | 16.00 | 9,000,000 |
| 2019-11-04 | Vida Ventures, Llc | Buy | 185,000 | 16.00 | 2,960,000 |
| 2019-11-04 | Kkr Fund Holdings Gp Ltd | Buy | 155,000 | 16.00 | 2,480,000 |
| 2019-11-04 | Versant Side Fund Iv, L.p. (10% Owner) | Buy | 590,000 | 16.00 | 9,440,000 |
| 2019-11-04 | Sandell Scott D (10% Owner) | Buy | 935,000 | 16.00 | 14,960,000 |
| 2019-11-04 | Link William J Phd (Director) | Buy | 27,500 | 16.00 | 440,000 |
| 2019-11-04 | Lainovic Sacha (Director) | Buy | 750,000 | 16.00 | 12,000,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of OYST listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Oyster Point Pharma, Inc. (symbol OYST, CIK number 1720725) see the Securities and Exchange Commission (SEC) website.